AI BriefingCohere Expands Sovereign Enterprise AI with Reliant AI Acquisition
Key point
Cohere has acquired Reliant AI to expand sovereign AI for biopharma.
Details
Cohere has acquired Reliant AI to expand sovereign enterprise AI for global biopharma and healthcare. Reliant AI's research team, biomedical datasets, and domain-optimized technology, based in Montreal and Berlin, will join Cohere's enterprise AI platform.
The combination focuses on helping enterprises and governments deploy AI while directly controlling data, infrastructure, and compliance boundaries in environments where security, data privacy, and regulatory compliance matter. Cohere will build on its established presence in Canada and Germany and its momentum in Europe to expand into the healthcare and life sciences market.
Reliant AI's flagship product is a research workbench that automates the following tasks for global biopharma organizations.
- Systematic literature review
- Competitive landscape analysis
- Extraction of unstructured scientific and regulatory data
- Treatment precedent identification and market feasibility modeling
North for Pharma will accelerate development on top of these capabilities, expanding into agentic AI for R&D, clinical development, and scientific analytics teams. Cohere will also inherit customer relationships with GSK, Medicus Pharma, and Kyowa Kirin, and Reliant AI was founded in 2023 by Karl Moritz Hermann, Richard Schlegel, and Marc G. Bellemare. Hermann will join Cohere in Berlin as VP of AI Verticalizations, and Bellemare will join in Montreal as VP of Modelling.
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.